The Clinical Desire for Pressurized Intraperitoneal Aerosol Chemotherapy in South Korea: An Electronic Survey-based Study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Eun Ji | - |
dc.contributor.author | Park, Soo Jin | - |
dc.contributor.author | Lee, Jeesun | - |
dc.contributor.author | Mun, Jaehee | - |
dc.contributor.author | Paik, Haerin | - |
dc.contributor.author | Seol, Aeran | - |
dc.contributor.author | Kim, Junhwan | - |
dc.contributor.author | Yim, Ga Won | - |
dc.contributor.author | Shim, Seung-Hyuk | - |
dc.contributor.author | Kim, Hee Seung | - |
dc.contributor.author | Chang, Suk-Joon | - |
dc.date.accessioned | 2024-06-13T06:30:27Z | - |
dc.date.available | 2024-06-13T06:30:27Z | - |
dc.date.issued | 2022-01 | - |
dc.identifier.issn | 0250-7005 | - |
dc.identifier.issn | 1791-7530 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/74159 | - |
dc.description.abstract | Background/Aim: To evaluate the clinical desire for pressurized intraperitoneal aerosol chemotherapy (PIPAC) in South Korea. Patients and Methods: We performed an online survey on surgical oncologists between November and December 2019 using a questionnaire consisting of 20 questions. Results: A total of 164 respondents answered the questionnaire. Among those specialized in ovarian cancer, pseudomyxoma peritonei, and malignant mesothelioma 41.7-50% preferred PIPAC for the curative treatment of primary diseases, whereas 32.7-33.3% majoring in colorectal and hepatobiliary cancers chose it for the palliative treatment of recurrent diseases. Furthermore, 66.795.2% considered PIPAC appropriate for the cancers they specialized in, and 76-78.7% expected a treatment response of more than 50% and considered grade 1 or 2 complications acceptable. Most respondents answered the reasonable costs to purchase and implement PIPAC once at between 1,000,000-5,000,000 South Korean Won (KRW). Conclusion: Most Korean surgical oncologists expected relatively high tumor response rates with minor toxicities through the repeated implementation of PIPAC. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | INT INST ANTICANCER RESEARCH | - |
dc.title | The Clinical Desire for Pressurized Intraperitoneal Aerosol Chemotherapy in South Korea: An Electronic Survey-based Study | - |
dc.type | Article | - |
dc.identifier.doi | 10.21873/anticanres.15494 | - |
dc.identifier.bibliographicCitation | ANTICANCER RESEARCH, v.42, no.1, pp 363 - 371 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000739751600006 | - |
dc.identifier.scopusid | 2-s2.0-85121986771 | - |
dc.citation.endPage | 371 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 363 | - |
dc.citation.title | ANTICANCER RESEARCH | - |
dc.citation.volume | 42 | - |
dc.type.docType | Article | - |
dc.publisher.location | 그리이스 | - |
dc.subject.keywordAuthor | Pressurized intraperitoneal aerosol chemotherapy | - |
dc.subject.keywordAuthor | peritoneal metastasis | - |
dc.subject.keywordAuthor | survey | - |
dc.subject.keywordAuthor | clinical desire | - |
dc.subject.keywordAuthor | prerequisite | - |
dc.subject.keywordAuthor | cost | - |
dc.subject.keywordPlus | CYTOREDUCTIVE SURGERY | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.